Australia
US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER
SYDNEY, June 17, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Orphan Drug Designation (ODD) to Kazia's paxalisib for the treatmen...
2022-06-17 20:00
5059
Bechtel launches second round of STEM Returners program
Career-break engineers helping to shape team performance BRISBANE, Australia, June 16, 2022 /PRNewswire/ -- Bechtel announced today launch of second intake of STEM returners at theirAustralia offices in Brisbane andPerth following the success of the pilot program in 2021. The new intake will ope...
2022-06-17 10:05
3218
LiveHire and Enboarder Announce Partnership to Deliver Next-Generation Onboarding Experience
The integrated solution combines the power of LiveHire's Total Talent and Direct Sourcing Platform with Enboarder's People Activation Platform to deliver more personalized experiences for onboarding new talent MIAMI, June 15, 2022 /PRNewswire/ -- LiveHire Ltd. (ASX: LVH), a global software-as-a-...
2022-06-16 01:00
3178
LexisNexis Risk Solutions Study Estimates Australian Financial Services Firms Will Spend More Than U.S. $2.54 Billion on Financial Crime Compliance in 2022
Retail and Ecommerce Merchants Projected to Have Highest Money Laundering Risks SYDNEY, June 15, 2022 /PRNewswire/ -- LexisNexis® Risk Solutions today released its firstAustralia edition of the LexisNexis True Cost of Compliance™ Study. The study revealed that Australian financial services compa...
2022-06-15 08:00
3127
Telix and Invicro Advance AI Partnership
MELBOURNE, Australia and BOSTON, June 14, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has advanced a partnership with Invicro LLC (Invicro), a global, industry-leading imaging CRO, and part of REALM IDx, Inc., to develop an artificial...
2022-06-14 19:00
2904
TradeWindow Standardises on Nintex Promapp to Support Global Growth
Software development company uses Nintex Promapp to discover, map, manage and govern its organisational business processes MELBOURNE, Australia, June 14, 2022 /PRNewswire/ -- Nintex, the global standard for process intelligence and automation, today announced that software company TradeWindow ha...
2022-06-14 07:17
2856
Jubilant Radiopharma Joins Illuccix® Pharmacy Partner Network
MELBOURNE, Australia and INDIANAPOLIS, June 13, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce that its prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga 68 gozetotide), is now available at selected pharmacies in ...
2022-06-13 19:11
3104
Novavax COVID-19 Vaccine Nuvaxovid™ Provisionally Registered in Australia as a Booster in Individuals Aged 18 and Over
* In Australia, Nuvaxovid™ is the first protein-based COVID-19 vaccine registered for use as a booster regardless of previous vaccine history GAITHERSBURG, Md., June 13, 2022 /PRNewswire/ -- Novavax, Inc. (NASDAQ: NVAX), a biotechnology company dedicated to developing and commercializing next-...
2022-06-13 19:00
3160
POSITIVE DATA FOR PAXALISIB IN TWO CHILDHOOD BRAIN CANCERS PRESENTED AT 20TH ISPNO ANNUAL MEETING
SYDNEY, June 13, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the presentation of new data regarding the activity of paxalisib in two forms of childhood brain cancer with poor prognosis and limited t...
2022-06-13 19:00
5439
Telix and RefleXion Expand Partnership for Prostate Cancer Treatment
MELBOURNE, Australia and INDIANAPOLIS, June 10, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RefleXion Medical, Inc. (Hayward, California, U.S.) (RefleXion) today announced the signing of a co-development and commercialisation agreement, to expand the use ...
2022-06-10 19:00
3804
RAD adds brain tumor technology to portfolio
* Sublicensing of promising imaging & therapeutic radiopharmaceutical from leading US university,Case Western Reserve University (CWRU), Ohio * PTPµ (PTPmu), the target, is a unique biomarker present only in tumor cells but not healthy cells * The radionuclide carrying PTPµ-targeting agent h...
2022-06-10 10:21
2990
World leading organisations support IAF's global certificate database
SYDNEY, June 9, 2022 /PRNewswire/ -- The International Accreditation Forum
2022-06-09 23:00
4079
Techtronic Industries Australia selects One Network Enterprises to Enhance Supplier Collaboration for Improved Demand and Supply Planning
One Network's Leading Control Tower will be deployed on its Digital Supply Chain Network™ to deliver multi-tier visibility, collaboration, and execution capabilities, to accelerate TTI's digital transformation. DALLAS, June 7, 2022 /PRNewswire/ -- One Network Enterprises(ONE), the leading global...
2022-06-07 21:00
3124
Telix to Present at Jefferies Healthcare Conference
MELBOURNE, Australia and INDIANAPOLIS, June 7, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR) advises t...
2022-06-07 19:00
2520
PHASE II STUDY OF PAXALISIB IN BRAIN METASTASES ADVANCES TO EXPANSION STAGE IN BREAST CANCER BRAIN METASTASES COHORT
SYDNEY, June 7, 2022 Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that a phase II, genomically-guided study of multiple therapies in patients with brain metastases, led by the Alliance for Clinical Trials in Oncology (NC...
2022-06-07 19:00
3058
Landis+Gyr's EV Charging Business Picks Up Speed with Software Contract in New Zealand
Meridian Energy will deploy the OCEAN Charge Point Management System for the management and monetization of their public charging network across the country. CHAM, Switzerland, June 7, 2022 /PRNewswire/ -- Etrel, a Landis+Gyr (SIX: LAND) company providing integrated e-mobility solutions, and Meri...
2022-06-07 16:00
2309
IND approval from the US FDA for Phase II SAR-Bombesin imaging trial in prostate cancer
Highlights * IND approval received for SAR-Bombesin product, enabling a Phase II "SABRE" imaging trial to detect prostate cancer in up to 50 PSMA-negative participants in the US * Approximately 20% of prostate cancer patients with biochemical recurrence (BCR) are PSMA-PET negative and theref...
2022-06-06 21:08
3017
Pepper Money's SOLANA Improves Business Volumes by 70% with the Appian Low-Code Platform
SYDNEY, June 6, 2022 /PRNewswire/ -- Appian (NASDAQ: APPN) announced today that Pepper Money, a leading consumer finance company inAustralia is using the Appian Low-Code Platform to support its Asset Finance Loan Origination solution, SOLANA, which has allowed the company to grow its business vol...
2022-06-06 07:00
4426
KAZIA PRESENTS POSITIVE FINAL DATA FROM PHASE II STUDY OF PAXALISIB IN NEWLY DIAGNOSED GLIOBLASTOMA AT ASCO CONFERENCE
SYDNEY, June 3, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce final data from its phase II study of paxalisib as first line therapy in patients with glioblastoma (NCT03522298). The data is the subj...
2022-06-03 19:00
9814
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial for the Treatment of Patients with Multiple System Atrophy
Multiple System Atrophy is a rare, rapidly progressive, neurodegenerative disease that causes profound disability MELBOURNE, Australia, June 2, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disea...
2022-06-02 20:00
3411
Week's Top Stories
Most Reposted
Hong Leong Bank Unveils HLB opus Extended Exclusively by Private Invitation
[Picked up by 317 media titles]
2026-09-03 23:53
Agoda Named Official Travel Partner of Eurovision's Inaugural Asian Edition
[Picked up by 312 media titles]
2026-09-02 12:17
Visa Launches Enhanced A2A Protect Innovations to Help Financial Institutions Stop Fraud Before Money Leaves Accounts
[Picked up by 311 media titles]
2026-09-02 08:30Klook Takes Creator Commerce Beyond Influence With Kreator Shops
[Picked up by 307 media titles]
2026-09-01 11:00
DayOne and TNB Explore Up To 1.5 GW of On-Site Power Generation to Advance Malaysia's Energy Resilience and Digital Economy
[Picked up by 292 media titles]
2026-09-01 17:36Most Read
Klook Takes Creator Commerce Beyond Influence With Kreator Shops
2026-09-01 11:00
7899
YY Group Enters New Era as YYForce, Expanding AI, Automation and Human-Robot Workforce Strategy; Nasdaq Ticker Changes to "YFOR"
2026-09-01 04:10
7857
Agoda Named Official Travel Partner of Eurovision's Inaugural Asian Edition
2026-09-02 12:17
7626
